Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Abaji, Mario, Munnich, Arnold, Racowsky, Catherine, Fossard, Camille, Vandame, Jessica, Labro, Mathilde, Benammar, Achraf, Ayoubi, Jean-Marc, Poulain, Marine
Format: Artículo científico
Sprache:en
Veröffentlicht: Reproductive biomedicine online 2025
Schlagworte:
Online-Zugang:https://pubmed.ncbi.nlm.nih.gov/40582023/
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1868266184108933122
author Abaji, Mario
Munnich, Arnold
Racowsky, Catherine
Fossard, Camille
Vandame, Jessica
Labro, Mathilde
Benammar, Achraf
Ayoubi, Jean-Marc
Poulain, Marine
author_facet Abaji, Mario
Munnich, Arnold
Racowsky, Catherine
Fossard, Camille
Vandame, Jessica
Labro, Mathilde
Benammar, Achraf
Ayoubi, Jean-Marc
Poulain, Marine
Abaji, Mario
Munnich, Arnold
Racowsky, Catherine
Fossard, Camille
Vandame, Jessica
Labro, Mathilde
Benammar, Achraf
Ayoubi, Jean-Marc
Poulain, Marine
collection PubMed - marine biology
contents Preconception carrier screening among assisted reproduction patients: insights from a monocentric survey in France. Abaji, Mario Munnich, Arnold Racowsky, Catherine Fossard, Camille Vandame, Jessica Labro, Mathilde Benammar, Achraf Ayoubi, Jean-Marc Poulain, Marine Humans France Reproductive Techniques, Assisted Female Genetic Carrier Screening Adult Prospective Studies Preconception Care Surveys and Questionnaires Male Genetic Testing What are the opinions of individuals undergoing assisted reproductive technology in France on preconception genetic carrier screening for monogenic Mendelian diseases? A prospective monocentric study using an anonymous online questionnaire to target patients who underwent a consultation at the Assisted Reproductive Technology (ART) service of the Obstetrics and Reproductive Medicine Department, Foch Hospital, between January 2021 and October 2023. Of the 7793 patients successfully contacted by email, 1206 responded to the survey, yielding a 15.5% response rate. Most participants (90.8% [1091/1202]) agreed or strongly agreed that preconception genetic carrier screening represents a significant advancement in the field of assisted reproductive technology, 41.9% (501/1195) documented that such screening should be available to all couples planning to have children and 43.1% (515/1195) supported such screening being available to any adult wishing to know their carrier status. Support for preconception genetic carrier screening is strong among patients undergoing assisted reproduction. This patient population is ideal for initiating essential pilot studies in France concerning such screening. These studies are crucial for understanding and addressing economic and technological challenges, as well as advancing ethical considerations in this emerging field.
format Artículo científico
id pubmed_40582023
institution PubMed
language en
publishDate 2025
publisher Reproductive biomedicine online
record_format pubmed
spellingShingle Preconception carrier screening among assisted reproduction patients: insights from a monocentric survey in France.
Abaji, Mario
Munnich, Arnold
Racowsky, Catherine
Fossard, Camille
Vandame, Jessica
Labro, Mathilde
Benammar, Achraf
Ayoubi, Jean-Marc
Poulain, Marine
Humans
France
Reproductive Techniques, Assisted
Female
Genetic Carrier Screening
Adult
Prospective Studies
Preconception Care
Surveys and Questionnaires
Male
Genetic Testing
Preconception carrier screening among assisted reproduction patients: insights from a monocentric survey in France. Abaji, Mario Munnich, Arnold Racowsky, Catherine Fossard, Camille Vandame, Jessica Labro, Mathilde Benammar, Achraf Ayoubi, Jean-Marc Poulain, Marine Humans France Reproductive Techniques, Assisted Female Genetic Carrier Screening Adult Prospective Studies Preconception Care Surveys and Questionnaires Male Genetic Testing What are the opinions of individuals undergoing assisted reproductive technology in France on preconception genetic carrier screening for monogenic Mendelian diseases? A prospective monocentric study using an anonymous online questionnaire to target patients who underwent a consultation at the Assisted Reproductive Technology (ART) service of the Obstetrics and Reproductive Medicine Department, Foch Hospital, between January 2021 and October 2023. Of the 7793 patients successfully contacted by email, 1206 responded to the survey, yielding a 15.5% response rate. Most participants (90.8% [1091/1202]) agreed or strongly agreed that preconception genetic carrier screening represents a significant advancement in the field of assisted reproductive technology, 41.9% (501/1195) documented that such screening should be available to all couples planning to have children and 43.1% (515/1195) supported such screening being available to any adult wishing to know their carrier status. Support for preconception genetic carrier screening is strong among patients undergoing assisted reproduction. This patient population is ideal for initiating essential pilot studies in France concerning such screening. These studies are crucial for understanding and addressing economic and technological challenges, as well as advancing ethical considerations in this emerging field.
title Preconception carrier screening among assisted reproduction patients: insights from a monocentric survey in France.
topic Humans
France
Reproductive Techniques, Assisted
Female
Genetic Carrier Screening
Adult
Prospective Studies
Preconception Care
Surveys and Questionnaires
Male
Genetic Testing
url https://pubmed.ncbi.nlm.nih.gov/40582023/